Driving Innovation: The Path of the AI in Clinical Trials Market Towards USD 7.6 Billion by 2030 | Intent Market Research

According to Intent Market Research, the global AI in clinical trials market was valued at USD 1.8 billion in 2023 and is projected to surpass USD 7.6 billion by 2030, registering a remarkable compound annual growth rate (CAGR) of 23.0% during the forecast period of 2024–2030. This substantial growth is driven by the increasing adoption of AI-powered tools in drug discovery and clinical trial management.

Browse Complete Summary, Tables and Figures of the Report @ https://intentmarketresear...